Commonwealth Equity Services
BDSI

Commonwealth Equity Services’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Commonwealth Equity Services’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-47,200
Closed -$152K – 2345
2016
Q1 		$152K Buy
47,200
+15,500
+49% +$57.3K ﹤0.01% 1993
2015
Q4 		$152K Buy
31,700
+5,000
+19% +$28.3K ﹤0.01% 1953
2015
Q3 		$148K Buy
+26,700
New +$197K ﹤0.01% 1913

Other funds holding BDSI

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
EA
Emerald Acquisition Seattle, Washington $51.8B AUM

Commonwealth Equity Services's BDSI Position: Q2 2016 in Review

Commonwealth Equity Services sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2016, closing a stake of 47,200 shares — an estimated $152K sold.

Commonwealth Equity Services first reported a position in BDSI in Q3 2015 and held it in 3 quarters. The position peaked at $152K in Q1 2016. 88 funds tracked by Wall St. Rank hold BDSI as of Q2 2016.

  • Commonwealth Equity Services reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2016 after selling out during the quarter.
  • Commonwealth Equity Services sold 47,200 BioDelivery Sciences International, Inc. shares in Q2 2016, an estimated $152K.
  • Commonwealth Equity Services first reported a position in BioDelivery Sciences International, Inc. in Q3 2015 and held it in 3 quarters.
  • Commonwealth Equity Services's BioDelivery Sciences International, Inc. position peaked at $152K in Q1 2016.
  • 88 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2016.

Based on Commonwealth Equity Services's 13F filing for Q2 2016, filed 4 Aug 2016.